Doxazosin in the Treatment of Benign Prostatic Hyperplasia in Normotensive Patients: A Multicenter Study-Reference-Cited by-同舟云学术

Doxazosin in the Treatment of Benign Prostatic Hyperplasia in Normotensive Patients: A Multicenter Study

Published:1995-07 Issue:1 Volume:154 Page:105-109
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Fawzy Ahmed¹,Braun Karl¹,Lewis George P.¹,Gaffney Michael¹,Ice Kathleen¹,

Affiliation:

1. Department of Urology, Louisiana State University Medical Center, New Orleans, Louisiana, Future Healthcare Research Center, Cincinnati, Ohio, Clinical Pharmacology Center, New Bedford, Massachusetts and Pfizer Central Research, New York, New York.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Benign prostatic disease. A growing challenge in the 1990s;Daneshgari;Postgrad. Med.,1993

2. The development of human benign prostatic hyperplasia with age;Berry;J. Urol.,1984

3. Boyle, P.: Epidemiology of BPH risk factors and concomitance with hypertension. Read at the 15th Congress of the European Society of Cardiology Satellite Meeting--'Unique Problems in the Treatment of the Older Hypertensive Male,' Nice, September 1993.

4. Role of alpha-adrenergic blockers in the treatment of benign prostatic hyperplasia;Lepor;Prostate,1990

5. Alpha-adrenergic blockers for the treatment of benign prostatic hyperplasia;Caine;Urol. Clin. N. Amer.,1990

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characteristics of Patients Who Visit Urologic Outpatient Department via Health Promotion Center;The Korean Journal of Urological Oncology;2022-08-31

2. Evolving Role of Silodosin for the Treatment of Urological Disorders – A Narrative Review;Drug Design, Development and Therapy;2022-08

3. The role of benign prostatic hyperplasia treatments in ejaculatory dysfunction;Fertility and Sterility;2021-09

4. Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III;Uro;2021-08-06

5. Role of alpha blockers in treating obstructive uropathy;Urologie pro praxi;2021-01-06